Lerner and Bagic 1 have to be congratulated for their hypothesis on PD pathogenesis. They suggest that the sequence of the brain changes in PD follows specific and repeatable patterns in all cases, as well as that a prion-like process underlies neurodegeneration. These ideas could explain several fe
The multidimensional measurement of the positive symptoms of psychosis
โ Scribed by Craig Steel; Philippa A. Garety; Daniel Freeman; Ellen Craig; Elizabeth Kuipers; Paul Bebbington; David Fowler; Graham Dunn
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 153 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1049-8931
- DOI
- 10.1002/mpr.203
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
The measures most frequently used to assess psychotic symptoms fail to reflect important dimensions. The Psychotic Symptom Rating Scale (PSYRATS) aims to capture the multidimensional nature of auditory hallucinations and delusions. Individuals (N = 276) who had recently relapsed with positive symptoms completed the auditory hallucinations and delusions PSYRATS scales. These scores were compared with the relevant items from the SAPS and PANSS, and with measures of current mood. Total scores and distribution of items of the PSYRATS scales are presented and correlated with other measures. Positive symptom items from the SAPS and PANSS reflected the more objective aspects of PSYRATS ratings of auditory hallucinations and delusions (frequency and conviction) but were relatively poor at measuring distress. A major strength of the PSYRATS scales is the specific measurement of the distress dimension of symptoms, which is a key target of psychological intervention. It is advised that the PSYRATS should not be used as a total score alone, whilst further research is needed to clarify the best use of potential subscales. Copyright ยฉ 2007 John Wiley & Sons, Ltd.
๐ SIMILAR VOLUMES
Neuroleptics have a deยฎnite role in dementia but the treatment targets need to be more narrowly deยฎned. Symptom clusters that are neuroleptic-responsive (e.g., aggression, psychomotor agitation and psychosis) appear to be emerging but need clearer deยฎnition and measurement. A number of these symptom